The Oncology Biosimilars Market analysis is rapidly evolving as the global burden of cancer continues to increase, driving demand for effective and affordable biologic therapies. Oncology biosimilars, which are highly similar to existing biologic drugs in terms of safety, efficacy, and quality, are gaining widespread acceptance among healthcare providers and patients. Rising incidences of...